Strain Name: |
C57BL/6-Itgb7tm1Mshi/J |
|---|---|
Stock Number: |
007707 |
Availability: | Repository- Live |
General Terms and Conditions |
| Genes & Alleles | Itgb7; Itgb7tm1Mshi; |
Type JAX® GEMM® Strain - Coisogenic Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Targeted Mutation Mating System Heterozygote x Heterozygote (Female x Male) Species laboratory mouse Donating Investigator Motomu Shimaoka, Immune Disease Institute (formerly CBRI) Generation N10F?+ (27-MAY-08) Strain Description
Mice homozygous for this b7 (D146A) targeted mutation are viable and fertile. DNA sequencing confirms an aspartate (D) to alanine (A) substitution at position 146 of the targeted b7 integrin gene. As such, homozygotes have a mutant ADMIDAS (adjacent to metal ion-dependent adhesion site) cation binding/exchange site in the b7 integrin head (A-domain). The resulting imbalance between the non-adhesive and adhesive states of leukocyte integrins skews toward a persistently adhesive state. Homozygous mutants exhibit impaired leukocyte migration, perturbed lymphocyte trafficking in the gut, and reduced T- and B-cell numbers in small/large bowel and gut-associated lymphoid tissues (less T-cells in Peyer's patches (PP), fewer intraepithelial lymphocyte (IEL) and lamina propria lymphocyte (LPL) compartments in the small intestine; and less B-cells in PP and the large intestine). In addition, CD4+CD45RBhigh T cells isolated from b7 (D146A) homozygotes have reduced colitogenic potential compared to CD4+CD45RBhigh T cells taken from wildtype mice following adoptive transfer. As the mouse integrin b7 chain is found as a cell surface heterodimer in association with either of two alpha chains (a4 or aE), these b7 (D146A) mutant mice may be useful in studying intestinal leukocyte migration and trafficking, integrin/ligand interactions (VCAM-1, fibronectin, MadCAM-1, E-cadherin), intraepithelial lymphocytes, and inflammatory bowel diseases.Of note, many strains harboring integrin beta mutant alleles are available from The Jackson Laboratory, including Itgb1-deficient (beta-1 null; Stock No. 003096), Itgb1-flox (Stock No. 004605), Itgb2-hypomorph (CD18-hypo; Stock No. 002128), Igtb2-deficient (CD18-null or beta2-null; Stock No. 003329), Itgb3-deficient (beta3-null; Stock No. 004669), Itgb5-deficient (beta5-null; Stock No. 004166), Itgb7-deficient (beta7-null; Stock No. 002965 and Stock No. 004944), and Itgb7D146A mutant (Stock No. 007707) strains.
Strain Development
To generate this mutant allele, an ACN targeting vector was designed to insert (by site-directed mutagenesis) a single amino acid substitution of aspartic acid to alanine at codon 146 (D146A) into exon 4, and an engineered EcoRI site downstream of exon 4 of the targeted gene. The ACN cassette, containing the neomycin resistance gene and Cre recombinase gene under the control of the sperm-specific angiotensin-converting enzyme promoter, is flanked by loxP sites. Cre-mediated recombination during spermatogenesis of chimeric males removes the cassette leaving a single loxP site between exons 2-3. The construct was electroporated into C57BL/6-derived Bruce-4 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts, and the resulting chimeric males were crossed to C57BL/6 females. Heterozygous b7 (D146A) mice (harboring the D146A substitution, EcoRI insertion, and single remaining loxP site) were bred together for many generations prior to arrival at The Jackson Laboratory.
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Itgb7tm1Mshi | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Motomu Shimaoka | ||
| Common Name(s) | Itgb7D146A; | ||
| Mutation Made By | Motomu Shimaoka, Immune Disease Institute (formerly CBRI) | ||
| Strain of Origin | C57BL/6 | ||
| ES Cell Line Name | Bruce 4 | ||
| ES Cell Line Strain | C57BL/6 | ||
| Gene Symbol and Name | Itgb7, integrin beta 7 | ||
| Chromosome | 15 | ||
| Molecular Note | A vector consisting of a cre recombinase and a neomycin resistant gene under the control of the sperm-specific ACE promoter was used for targeting exon 4. In exon 4, the sequence encoding amino acid 146 was changed from an aspartate to an alanine (D146A). This mutation was predicted to keep the integrin in a constitutively adhesive state. The cre-recombinase and the neomycin resistance gene were excised in chimeras during spermatogenesis, leaving behind one loxP site. The mutation was confirmed by genomic sequencing. [MGI Ref ID J:127413] | ||
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Itgb7tm1Mshi
| Breeding & Husbandry | When maintaining a live colony, these mice may be bred as homozygotes. |
|---|---|
| Diet Information | LabDiet® 5K52/5K67 |
Strains carrying other alleles of Itgb7
002965 C57BL/6-Itgb7tm1Cgn/J 004944 NOD.B6-Itgb7tm1Cgn/2LtJ 004943 NOD.Cg-Selltm1Tft Itgb7tm1Cgn/LtJ View Strains carrying other alleles of Itgb7 (3 strains)
Room Number AX11
Cancer Research
Defects in Cell Adhesion Molecules
Cell Biology Research
Defects in Cell Adhesion Molecules
Developmental Biology Research
Defects in Cell Adhesion Molecules
Internal/Organ Defects (Lymphoid Tissue Defects)
Lymphoid Tissue Defects
Hematological Research
Immunological Defects (B and T cell deficiency)
Immunology and Inflammation Research
Immunodeficiency (B and T cell deficiency)
Immunodeficiency (B cell defects)
Immunodeficiency (B cell deficiency)
Immunodeficiency (Inflammatory bowel disease)
Immunodeficiency (T cell deficiency)
Inflammation (B and T cell deficiency)
Inflammation (Inflammatory bowel disease)
Lymphoid Tissue Defects (B and T cell deficiency)
Lymphoid Tissue Defects (Lymphocyte Homing)
Internal/Organ Research
Gastrointestinal Defects (colitis)
Lymphoid Tissue Defects (B and T cell deficiency)
Lymphoid Tissue Defects (T cell deficiency)
Research Tools
Cancer Research (B cell deficiency)
Cancer Research (T cell deficiency)
Immunology and Inflammation Research (B and T cell deficiency)
Immunology and Inflammation Research (B cell deficiency)
Immunology and Inflammation Research (T cell deficiency)
Virology Research
B and T Cell Deficiency
Selected Reference(s)
Park EJ; Mora JR; Carman CV; Chen J; Sasaki Y; Cheng G; von Andrian UH; Shimaoka M. 2007. Aberrant activation of integrin alpha4beta7 suppresses lymphocyte migration to the gut. J Clin Invest 117(9):2526-38. [PubMed: 17786243] [MGI Ref ID J:127413]
| Strain Name: | C57BL/6-Itgb7tm1Mshi/J |
| Stock Number: | 007707 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
Usually shipped between four and eight weeks of age. This strain is included in the Induced Mutant Resource Colony collection. |
| Licensing | See General Terms and Conditions below |
| Control Information | View Control Information in Strain Details. |
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form